<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">

<channel>
<title><![CDATA[Chugai Pharmaceutical: News Releases]]></title>
<link>https://www.chugai-pharm.co.jp/english/index.html</link>
<description><![CDATA[News Releases]]></description>
<category><![CDATA[News Releases]]></category>
<language>en-us</language>
<copyright><![CDATA[Copyright(C) Chugai Pharmacetical Co.,Ltd. All rights reserved.]]></copyright>
<lastBuildDate>Wed, 29 Jul 2026 17:30:00 +0900</lastBuildDate>

<item>
<title><![CDATA[Support for Areas Affected by the 2026 Kumamoto Prefecture Earthquake]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260729173000_1276.html</link>
<description></description>
<category></category>
<pubDate>Wed, 29 Jul 2026 17:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260729173000_1276.html</guid>
</item>
<item>
<title><![CDATA[Chugai Announces 2026 2nd Quarter Results]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260724160000_1265.html</link>
<description></description>
<category></category>
<pubDate>Fri, 24 Jul 2026 16:00:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260724160000_1265.html</guid>
</item>
<item>
<title><![CDATA[F. Hoffmann-La Roche Announces Half Year Results 2026]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260723140000_1264.html</link>
<description></description>
<category></category>
<pubDate>Thu, 23 Jul 2026 14:00:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260723140000_1264.html</guid>
</item>
<item>
<title><![CDATA[Roche’s Announcement Regarding divarasib (Announcement of Phase III Krascendo1 Study Results) ]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260702153000_1262.html</link>
<description></description>
<category></category>
<pubDate>Thu, 02 Jul 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260702153000_1262.html</guid>
</item>
<item>
<title><![CDATA[Launch of Joint Research Using Real-World Data and Generative AI (LLM) to Improve the Accuracy and Efficiency of Identifying Candidate Patients for Clinical Trials]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260630153000_1259.html</link>
<description></description>
<category></category>
<pubDate>Tue, 30 Jun 2026 15:30:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260630153000_1259.html</guid>
</item>
<item>
<title><![CDATA[Roche’s Announcement Regarding Enspryng (FDA Accepts Application for Thyroid Eye Disease)]]></title>
<link>https://www.chugai-pharm.co.jp/english/news/detail/20260630170000_1260.html</link>
<description></description>
<category></category>
<pubDate>Tue, 30 Jun 2026 17:00:00 +0900</pubDate>
<guid>https://www.chugai-pharm.co.jp/english/news/detail/20260630170000_1260.html</guid>
</item>

</channel>
</rss>
